News
Our latest research, highlighting the ability of OmegaPro to enrich eggs to deliver improvements in human health was presented at the recent European Symposium on Poultry Nutrition in Italy.
The work, carried out in partnership with the University of Guelph, was presented as a poster by Anderson Maina, the PhD candidate running the trial.
Trial details
The trial assessed the performance of OmegaPro and crude algal oil. There were five treatments:
Treatments three and five were included to show that even at very high levels, there would be no negative impact on the birds.
There were a total of 400 Lohmann LSL Lite layer hens at 46 weeks of age, with 8 replicates per treatment, and with 10 layers per cage. Egg production was monitored weekly for 10 weeks. Fatty acid analysis was conducted on both egg and feed samples throughout, and meat samples were taken at the end of the trial.
Delivering an important source of omega-3 DHA in eggs and tissues
The trial showed that across the treatments OmegaPro-enriched eggs and hens delivered superior levels of DHA compared to control and crude algal oil, contributing towards improved heart, brain, and vision health of consumers. The omega-3 DHA level of the spent hen meat was also increased, thereby improving its nutritive value.
Total omega-3 fatty acid levels were also increased in the OmegaPro enriched diets compared to the control and crude algal oil diets.
None of the treatments had any negative effects on egg production or quality.
If you would like to know more about this trial and how Humanativ could help your poultry business to bring innovation to the egg category, please click here
